05 Compliance

Where calcium bisglycinate is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-18 · Calcium Bisglycinate

On this page
  1. Four checks, one file
  2. European Union
  3. United States
  4. Contaminant limits
  5. The claim boundary
  6. The document file
  7. Pre-shipment checklist

Calcium bisglycinate is a permitted calcium source for food supplements in the EU and Great Britain, and it is sold in the US as a dietary ingredient. Each market asks a different question: the EU checks the form, the contaminants, the label and the claim; the US checks the ingredient basis, the Supplement Facts panel and the claim; the UK checks its retained list and claims register.

In one line

A permitted form, a contaminant ceiling, a label and a claim are four different questions, and each market answers them its own way.

Four checks, one file

Four checks sit between the powder and a lawful label: the permitted form, the contaminant ceiling, the supplement label and the claim. The certificate supports all four but does not answer them alone; the operator is responsible for the form, the dose, the label and the claim. This is a sourcing reference, not legal advice.

Great Britain works from a retained permitted-forms list. The 2003 Food Supplements (England) Regulations and their devolved counterparts carry it, and calcium bisglycinate is on the GB list; a UK launch checks that list rather than the EU text. GB retained the contaminant ceilings and the 800 mg reference value, and Northern Ireland follows the EU list under the Windsor Framework. The UK label follows the retained food information rules and carries the UK address of the food business operator. Confirm the current GB wording before printing.

European Union

Directive 2002/46/EC sets a positive list of permitted vitamin and mineral forms for food supplements. Calcium bisglycinate appears in Part B of Annex II, so the form is permitted; the consolidated text is the reference.

Regulation (EU) 2023/915 applies from 25 May 2023 and replaced Regulation (EC) No 1881/2006. Section 3 of the Annex sets lead at 3.0 mg/kg, cadmium at 1.0 mg/kg and mercury at 0.10 mg/kg for food supplements. There is no harmonised EU limit for arsenic, so the buyer sets one; the limits apply to the supplement as sold, so the ingredient's contribution is calculated from the dose.

Regulation (EU) No 1169/2011 sets the general food information rules, and Directive 2002/46/EC adds the supplement particulars: the food supplement statement, the nutrient and its amount per portion, the percentage of the nutrient reference value, the warning not to exceed the daily dose, the warning to keep the product out of reach of children, and the statement that the product is not a substitute for a varied diet. The calcium reference value is 800 mg.

Health claims are governed by Regulation (EC) No 1924/2006 and the authorised list in Regulation (EU) No 432/2012. A calcium claim has to use the authorised wording; the source-of condition is 15% of 800 mg, or 120 mg in the daily portion. The claim belongs to calcium, not to the chelate form.

United States

The US does not maintain a positive list of permitted supplement forms. A calcium bisglycinate supplement rests on the dietary ingredient definition in DSHEA, section 201(ff)(1). The file should say which basis applies: an NDI notification at least 75 days before marketing, a GRAS conclusion, or evidence of marketing before 15 October 1994.

The FDA does not approve a supplement or its label before sale. The Supplement Facts panel follows 21 CFR 101.36 and carries the serving size, the calcium per serving and the percentage of the Daily Value. The Daily Value for calcium is 1,300 mg for adults and children four years and older.

A structure/function claim must be truthful and substantiated; it carries the DSHEA disclaimer in 21 CFR 101.93, and the marketer notifies the FDA within 30 days of first marketing. Disease claims are not permitted. The cGMP rule in 21 CFR 111 requires identity testing, supplier qualification and batch records, so the buyer's identity test on receipt is part of the file.

There is no federal lead limit for supplements. California's Proposition 65 is the exposure rule many US buyers use: 0.5 µg/day maximum allowable dose for lead and 15 µg/day no-significant-risk level. Exposure is calculated from the daily dose.

Contaminant limits

Contaminant limits for calcium bisglycinate in a food supplement
MetalCatalog release limitEU limit (2023/915)GB limit (retained)US federal limit
Lead (Pb)≤3 mg/kg3.0 mg/kg3.0 mg/kgNone federal
Arsenic (As)≤2 mg/kgNo harmonised limitNo harmonised limitNone federal
Cadmium (Cd)≤1 mg/kg1.0 mg/kg1.0 mg/kgNone federal
Mercury (Hg)≤0.1 mg/kg0.10 mg/kg0.10 mg/kgNone federal

The catalog limits are release ceilings on the ingredient. The EU and GB limits apply to the supplement as sold, so the contribution is calculated from the dose. A buyer who needs a tighter arsenic limit writes it into the specification.

The claim boundary

The claim boundary is the same in all three markets: a disease claim is not permitted, and a nutrient claim has to stay inside the authorised wording and conditions. In the EU and UK that means the current register; in the US it means a structure/function claim with substantiation, the DSHEA disclaimer and the 30-day notification. A certificate is not a claim file.

The form is not a claim: “calcium bisglycinate” is an ingredient name and “chelate” describes the form; neither adds a permitted claim.

The document file

  • Specification naming the form, formula, CAS number, calcium range, loss on drying, mesh and density.
  • Batch COA with the method and result for each line, including the contaminant and microbiological panels.
  • Contaminant report against the EU or GB limits, with the buyer's arsenic limit.
  • Identity file: infrared spectrum, glycine reaction, glycine by HPLC and the calcium-to-glycine ratio.
  • Allergen, GMO, irradiation and animal-derived input statements.
  • Label worksheet with calcium per portion and the % NRV or % Daily Value.
  • Claim file with the register entry or the US substantiation, disclaimer and notification record.
  • Stability summary and lot traceability from the certificate to the pack.

Pre-shipment checklist

  1. Is the form named on the label on the current permitted list for the destination market?
  2. Do lead, cadmium and mercury meet 3.0, 1.0 and 0.10 mg/kg, and is an arsenic limit set by the buyer?
  3. Is calcium per portion calculated against 800 mg in the EU and UK, or 1,300 mg in the US?
  4. Does the artwork carry the supplement particulars, the daily-dose warning and the storage statement?
  5. Is every claim on the current register, or supported by a US substantiation file with the disclaimer and notification?
  6. Is the US dietary ingredient basis documented, and is the identity test on receipt planned under 21 CFR 111?
  7. Is the destination checked for Member State, GB or Northern Ireland rules before the label is signed?

The catalog specification is published on the calcium bisglycinate product page. The certificate lines are read on the COA page, the order details are on the MOQ page, and the market notes are in the EU, US and UK references.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation